Axogen (AXGN) said late Wednesday it plans to offer and sell $85 million of common stock in a proposed underwritten public offering.
It intends to grant underwriters a 30-day option to buy up to an additional $12.75 million of common stock.
The company said there is no assurance as to whether or when the offering may be completed, or the actual size or terms of the deal.
Axogen said it plans to use the proceeds to repay its term loan facility with Oberland Capital and for working capital, capital spending and other general corporate purposes.
Shares of Axogen were down more than 5% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments